Partner Jeffrey Fessler Represents Synergy Pharmaceuticals Inc. on $89.8 Million Registered Direct Offering of Common Stock
Press Release – New York, NY – May 6, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP is pleased to announce that the Firm has represented Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, on a registered direct offering of 29,948,334 shares of the Company’s common stock at a public offering price per share of $3.00 without an underwriter or placement agent.
Synergy raised $89.8 million in gross proceeds.
The Sichenzia Ross Friedman Ference LLP team was led by Partners Jeffrey J. Fessler and Stephen A. Cohen.
- Sichenzia Ross Ference LLP Represents A.G.P./ Alliance Global Partners as Placement Agent in $15M Registered Direct Offering of Arcimoto, Inc. - November 24, 2020
- Founding Partner Marc J. Ross, Esq. Quoted Regarding Cannabis SPACs Post U.S. Presidential Elections - November 23, 2020
- 2020 Income Tax Rates and Deductions - November 19, 2020